NSEOutcome of Board Meeting24 Aug 2026 · 24 Aug 2026, 06:58 pm

Outcome of Board Meeting

Gujarat Kidney And Super Speciality Limited · GKSL

✦ AI SummaryMgmt Change

Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2026. The Board has appointed Mrs. (Dr) Disha Bharpoda as Additional Non-Executive Independent Director with effect from August 24, 2026. The details as required under Regulation 30 of the Listing Regulations are enclosed as Annexure A.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2026.

Attachments (1)

📄

GKSL2025_24082026185840_Signed_Outcome_of_BM_24082026.pdf

pdf

Download →
View document text
Date: 24.08.2026 To, To, BSE Limited National Stock Exchange of India Limited Listing Department Listing Department “Exchange Plaza,” Phiroze Jeejeebhoy Towers, C-1, Block G, Bandra – Kurla Complex, 25th Floor, Dalal Street, Bandra (E), Mumbai - 400 051 Mumbai - 400 001 Scrip Code: 544666 Sub.: Outcome of the Board Meeting held on August 24, 2026 (“Meeting”) Dear Sir Pursuant to Regulation 30 and other applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board of Directors of the Company at their meeting held on today i.e. Monday, 24th August, 2026 inter alia, consider and approved the following matter: 1. Appointment of Additional Director: The Board has appointed Mrs. (Dr) Disha Bharpoda (DIN: 11897794) as Additional- Non Executive- Independent Director with effect from 24.08.2026 The details as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and SEBI Circular No. SEBI/HO/CFD/CFDPoD-2/CIR/P/2024/185 dated December 31, 2024 is enclosed as Annexure A 2. The Board of the Directors took note of the approval given by the Shareholders via Postal ballot to the following resolution – Resolution Type of approval To consider and approve Variation in the Objects / terms Special Resolution of utilisation of the Initial Public Offering (“IPO”) proceeds. The Meeting commenced at 4:30 P.M. and concluded at 5 P.M. You are requested to kindly take the same on record. Thanking You. For Gujarat Kidney and Super Speciality Limited Pragnesh Bharpoda Managing Director DIN: 01033141 Date: 24.08.2026 To, To, BSE Limited National Stock Exchange of India Limited Listing Department Listing Department “Exchange Plaza,” Phiroze Jeejeebhoy Towers, C-1, Block G, Bandra – Kurla Complex, 25th Floor, Dalal Street, Bandra (E), Mumbai - 400 051 Mumbai - 400 001 Scrip Code: 544666 Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Appointment of Additional Non-Executive Independent Director Dear Sir Pursuant to Regulation 30 of the Listing Regulations, it is hereby informed that based on the recommendation of the Nomination and Remuneration Committee of the Board, the Board of Directors of the Company in its Meeting today, 24-08-2026, appointed Mrs. Disha Bharpoda (DIN: 11897794) as an Additional Non-Executive Independent Director, not liable to retire by rotation, for a first term of five consecutive years, subject to the approval by the Members of the Company. The appointment shall be subject to the approval of Members at the next Annual General Meeting of the Company and compliance with Regulation 17(1C) and Regulation 25(2A) of the Listing Regulations and the relevant provisions of the Companies Act, 2013 shall be followed. Details with respect to the said appointment as required under Regulation 30(6) read with Para A (7) of Part - A of Schedule III of the SEBI Listing Regulations and SEBI Circular No. SEBI/HO/CFD/CFD PoD1/P/CIR/2023/123 dated 13th July 2023 are provided in Annexure A to this letter. Kindly take the same on your records. Thanking you, For Gujarat Kidney and Super Speciality Limited Pragnesh Bharpoda Managing Director DIN: 01033141 ANNEXURE A Details with respect to appointment of Additional Non-Executive Independent Director under Regulation 30(6) read with Para A (7) of Part A of Schedule III of the Listing Regulations and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023: Appointment of Mrs. Disha Bharpoda as the Additional Non-Executive Independent Director S. No. Particulars Description 1 Reason for change viz. Appointment as an Additional Non-Executive appointment, resignation, Independent Director, not liable to retire by removal, death or otherwise rotation, for a first term of five consecutive years, subject to the approval by the Members of the Company. 2 Date of appointment/ 24.08.2026 resignation & term of appointment. 3 Brief profile (in case of Mrs Disha Bharpoda has completed her MD in appointment) Radiology from Baroda Medical College, Maharaja Sayajirao University, Vadodara, Guajrat in the year 2021. Thereafter she worked as Senior Resident Doctor for 5 years and for last one she has started her own Radiology Centre. 4 Disclosure of relationships Mrs Disha Bharpoda is not related to any between directors (in case of Director of the Company appointment of a director). This is for your information and records. For Gujarat Kidney and Super Speciality Limited Pragnesh Bharpoda Managing Director DIN: 01033141